 Cronos Group Inc. CRON, 15.55 shares jumped 14 on Tuesday after the cannabis companys first-quarter revenue of 25 million beat the analyst estimate by 1 million. Raymond James analyst Rahul Sarugaser reiterated an outperform rating on the stock and said Cronos also reported a better-than-expected adjusted Ebitda loss of 18.9 million, against a target for an adjusted Ebitda loss of 27.5 million. 